accountBy Debra Sherman and Bill Berkrot NEW ORLEANS, April 4 (Reuters) - A new heart stent manufactured by Boston Scientific Corp (BSX.N The 1,530-patient study compared Boston Scientific's drug-eluting Promus Element stent with its older Promus, sold by...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 3-Boston Scientific stent study meets goal
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account